GRAIL Reports Topline Results from NHS-Galleri Trial of Multi-Cancer Early Detection Test
Results from the NHS-Galleri trial show that annual multi-cancer screening with the Galleri test reduced Stage IV diagnoses and significantly increased early cancer detection across England’s NHS population.
National Health Service | 20/02/2026 | By News Bureau | 261
Pharma Leaders Back UK Life Sciences Strategy, But ABPI Warns of Medicines Investment Gap
Pharmaceutical and medical technology leaders, including GSK, Sandoz, Accord Healthcare, Becton Dickinson, and Celltrion have welcomed the UK government’s new Life Sciences Sector Plan, recently unveiled as part of its flagship Industrial Strategy.
National Health Service | 19/07/2025 | By Dineshwori | 208
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy